1. Home
  2. NCEL vs MGIH Comparison

NCEL vs MGIH Comparison

Compare NCEL & MGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NCEL

NewcelX Ltd. Ordinary Shares

HOLD

Current Price

$3.42

Market Cap

22.0M

Sector

Health Care

ML Signal

HOLD

Logo Millennium Group International Holdings Limited

MGIH

Millennium Group International Holdings Limited

N/A

Current Price

$1.53

Market Cap

18.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
NCEL
MGIH
Founded
2008
1978
Country
Switzerland
Hong Kong
Employees
4
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Publishing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
22.0M
18.2M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
NCEL
MGIH
Price
$3.42
$1.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.8K
74.3K
Earning Date
05-12-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$1.11
52 Week High
$5.12
$4.84

Technical Indicators

Market Signals
Indicator
NCEL
MGIH
Relative Strength Index (RSI) 46.05 48.33
Support Level $2.95 $1.41
Resistance Level $3.62 $1.56
Average True Range (ATR) 0.29 0.11
MACD -0.07 -0.01
Stochastic Oscillator 40.59 21.63

Price Performance

Historical Comparison
NCEL
MGIH

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

About MGIH Millennium Group International Holdings Limited

Millennium Group International Holdings Ltd supplies paper-based packaging solutions, including inner packaging boxes produced with offset or flexo printing and outer corrugated boxes used for transportation, storage, pallets, and point-of-purchase displays. The company manufactures corrugated products of different sizes, shapes, thicknesses, and strengths according to customer specifications. It also operates a supply chain management business in Vietnam to service international clients who source their packaging needs from Vietnam and other ASEAN countries. The corrugated paper is durable, versatile, economical, and lightweight.

Share on Social Networks: